Modulation of integrin function in hematopoietic progenitor cells by CD43 engagement: Possible involvement of protein tyrosine kinase and phospholipase C-gamma
N. Anzai et al., Modulation of integrin function in hematopoietic progenitor cells by CD43 engagement: Possible involvement of protein tyrosine kinase and phospholipase C-gamma, BLOOD, 93(10), 1999, pp. 3317-3326
Attachment of cells to extracellular matrix components is critical for the
regulation of hematopoiesis. CD43 is a mucin-like transmembrane sialoglycop
rotein expressed on the surface of almost all hematopoietic cells. A highly
extended structure of extracellular mucin with negative charge may functio
n as a repulsive barrier to hematopoietic cells, However, some investigator
s have shown that CD43 has proadhesive properties, and engagement of CD43 h
as been reported to upregulate integrin-mediated cell adhesion in T cells.
We found that cross-linking of CD43 with monoclonal antibodies (MoAbs) enha
nced integrin alpha 4 beta 1 (very late antigen [VLA]-4) and alpha 5 beta 1
(VLA-5)-dependent adhesion of human cord blood CD34(+) cells to fibronecti
n, CD34(+) CD38(hi), but not CD34(+)CD38(-/low) cells responded significant
ly to the stimulus, suggesting that committed, but not stem and more immatu
re progenitors are sensitive to CD43-mediated activation of integrin, To el
ucidate the molecular mechanism leading to integrin activation, we used the
growth factor-dependent cell line MO7e, Cross-linking of CD43 induced tyro
sine phosphorylation of several intracellular molecules including the prote
in tyrosine kinase Syk, the protooncogene product Cbl, and phospholipase C
(PLC)-gamma 2 in MO7e cells. Moreover, protein tyrosine kinase inhibitor he
rbimycin A and PLC inhibitor U73122 both blocked CD43-induced enhancement o
f adhesion to fibronectin. These results indicate that signals mediated thr
ough CD43 may increase integrin affinity to fibronectin via a pathway depen
dent on protein tyrosine kinase and PLC-gamma activation in hematopoietic p
rogenitors. (C) 1999 by The American Society of Hematology.